287 related articles for article (PubMed ID: 35746817)
1. Association of Increased Programmed Death Ligand 1 Expression and Regulatory T Cells Infiltration with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection.
Jeng LB; Li TC; Hsu SC; Teng CF
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746817
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma levels of monocyte chemoattractant protein-1 in patients with hepatitis B virus pre-S2 gene deletion mutation predict a higher risk of hepatocellular carcinoma recurrence after curative surgical resection.
Jeng LB; Li TC; Wang J; Teng CF
Cancer; 2023 Sep; 129(17):2621-2636. PubMed ID: 37096803
[TBL] [Abstract][Full Text] [Related]
3. Increased Expression of Programmed Death Ligand 1 in Hepatocellular Carcinoma of Patients with Hepatitis B Virus Pre-S2 Mutant.
Teng CF; Li TC; Wang T; Wu TH; Wang J; Wu HC; Shyu WC; Su IJ; Jeng LB
J Hepatocell Carcinoma; 2020; 7():385-401. PubMed ID: 33365286
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection.
Teng CF; Li TC; Huang HY; Chan WL; Wu HC; Shyu WC; Su IJ; Jeng LB
PLoS One; 2020; 15(11):e0242748. PubMed ID: 33237972
[TBL] [Abstract][Full Text] [Related]
5. Increased infiltration of regulatory T cells in hepatocellular carcinoma of patients with hepatitis B virus pre-S2 mutant.
Teng CF; Li TC; Wang T; Liao DC; Wen YH; Wu TH; Wang J; Wu HC; Shyu WC; Su IJ; Jeng LB
Sci Rep; 2021 Jan; 11(1):1136. PubMed ID: 33441885
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus surface gene pre-S
Yen CJ; Ai YL; Tsai HW; Chan SH; Yen CS; Cheng KH; Lee YP; Kao CW; Wang YC; Chen YL; Lin CH; Liu T; Tsai HP; Wang JR; Su IJ; Huang W
Hepatology; 2018 Sep; 68(3):815-826. PubMed ID: 29350774
[TBL] [Abstract][Full Text] [Related]
7. Association of Low Serum Albumin Level with Higher Hepatocellular Carcinoma Recurrence in Patients with Hepatitis B Virus Pre-S2 Mutant after Curative Surgical Resection.
Jeng LB; Li TC; Hsu SC; Chan WL; Teng CF
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575311
[TBL] [Abstract][Full Text] [Related]
8. Disruption of SIRT7 Increases the Efficacy of Checkpoint Inhibitor via MEF2D Regulation of Programmed Cell Death 1 Ligand 1 in Hepatocellular Carcinoma Cells.
Xiang J; Zhang N; Sun H; Su L; Zhang C; Xu H; Feng J; Wang M; Chen J; Liu L; Shan J; Shen J; Yang Z; Wang G; Zhou H; Prieto J; Ávila MA; Liu C; Qian C
Gastroenterology; 2020 Feb; 158(3):664-678.e24. PubMed ID: 31678303
[TBL] [Abstract][Full Text] [Related]
9. Combination of Hepatitis B Virus Pre-S2 Gene Deletion Mutation and Tumor-Node-Metastasis Stage Predicts Higher Hepatocellular Carcinoma Recurrence after Curative Surgical Resection.
Jeng LB; Li TC; Chan WL; Teng CF
Biomedicines; 2023 Mar; 11(3):. PubMed ID: 36979902
[TBL] [Abstract][Full Text] [Related]
10. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
[TBL] [Abstract][Full Text] [Related]
11. Next-Generation Sequencing-Based Quantitative Detection of Hepatitis B Virus Pre-S Mutants in Plasma Predicts Hepatocellular Carcinoma Recurrence.
Teng CF; Li TC; Huang HY; Lin JH; Chen WS; Shyu WC; Wu HC; Peng CY; Su IJ; Jeng LB
Viruses; 2020 Jul; 12(8):. PubMed ID: 32722114
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy.
Umemoto Y; Okano S; Matsumoto Y; Nakagawara H; Matono R; Yoshiya S; Yamashita Y; Yoshizumi T; Ikegami T; Soejima Y; Harada M; Aishima S; Oda Y; Shirabe K; Maehara Y
J Gastroenterol; 2015 Jan; 50(1):65-75. PubMed ID: 24509608
[TBL] [Abstract][Full Text] [Related]
13. Pre-S deletions of hepatitis B virus predict recurrence of hepatocellular carcinoma after curative resection.
Li-Shuai Q; Yu-Yan C; Hai-Feng Z; Jin-Xia L; Cui-Hua L
Medicine (Baltimore); 2017 Oct; 96(43):e8311. PubMed ID: 29069001
[TBL] [Abstract][Full Text] [Related]
14. The Influence of Hepatitis B Viral Load and Pre-S Deletion Mutations on Post-Operative Recurrence of Hepatocellular Carcinoma and the Tertiary Preventive Effects by Anti-Viral Therapy.
Su CW; Chiou YW; Tsai YH; Teng RD; Chau GY; Lei HJ; Hung HH; Huo TI; Wu JC
PLoS One; 2013; 8(6):e66457. PubMed ID: 23805222
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus pre-S2 mutant large surface protein inhibits DNA double-strand break repair and leads to genome instability in hepatocarcinogenesis.
Hsieh YH; Chang YY; Su IJ; Yen CJ; Liu YR; Liu RJ; Hsieh WC; Tsai HW; Wang LH; Huang W
J Pathol; 2015 Jul; 236(3):337-47. PubMed ID: 25775999
[TBL] [Abstract][Full Text] [Related]
16. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation.
Itoh S; Yoshizumi T; Yugawa K; Imai D; Yoshiya S; Takeishi K; Toshima T; Harada N; Ikegami T; Soejima Y; Kohashi K; Oda Y; Mori M
Hepatology; 2020 Dec; 72(6):1987-1999. PubMed ID: 32112577
[TBL] [Abstract][Full Text] [Related]
17. The emerging role of hepatitis B virus pre-S2 deletion mutant proteins in HBV tumorigenesis.
Su IJ; Wang LH; Hsieh WC; Wu HC; Teng CF; Tsai HW; Huang W
J Biomed Sci; 2014 Oct; 21(1):98. PubMed ID: 25316153
[TBL] [Abstract][Full Text] [Related]
18. Association of PD-L1 gene polymorphisms and circulating sPD-L1 levels with HBV infection susceptibility and related liver disease progression.
Xuan Hoan N; Thi Minh Huyen P; Dinh Tung B; Phuong Giang D; Tat Trung N; Tien Sy B; Thi Tuan N; Thi Ngoc Dung D; Reddy Pallerla S; Velavan TP; Hong Bang M; Huu Song L
Gene; 2022 Jan; 806():145935. PubMed ID: 34478821
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.
Gao Q; Wang XY; Qiu SJ; Yamato I; Sho M; Nakajima Y; Zhou J; Li BZ; Shi YH; Xiao YS; Xu Y; Fan J
Clin Cancer Res; 2009 Feb; 15(3):971-9. PubMed ID: 19188168
[TBL] [Abstract][Full Text] [Related]
20. Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression.
Hoan NX; Huyen PTM; Binh MT; Trung NT; Giang DP; Linh BT; Dung DTN; Pallerla SR; Kremsner PG; Velavan TP; Bang MH; Song LH
Sci Rep; 2021 Apr; 11(1):7772. PubMed ID: 33833369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
